Fort Sheridan Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.1K | Hold |
|
|||||
|
2025
Q1 | $24.9K | Hold |
|
|||||
|
2024
Q4 | $27.7K | Buy |
|
|||||
|
2024
Q3 | $29.1K | Hold |
|
|||||
|
2024
Q2 | $32.1K | Hold |
|
|||||
|
2024
Q1 | $47.6K | Sell |
|
|||||
|
2023
Q4 | $44.6K | Sell |
|
|||||
|
2023
Q3 | $99K | Hold |
|
|||||
|
2023
Q2 | $118K | Buy |
|
|||||
|
2023
Q1 | $111K | Sell |
|
|||||
|
2022
Q4 | $98.2K | Hold |
|
|||||
|
2022
Q3 | $95K | Buy |
|
|||||
|
2022
Q2 | $125K | Buy |
|
|||||
|
2022
Q1 | $117K | Buy |
|
|||||
|
2021
Q4 | $130K | Buy |
|
|||||
|
2021
Q3 | $121K | Hold |
|
|||||
|
2021
Q2 | $137K | Buy |
|
|||||
|
2021
Q1 | $106K | Buy |
|